1. Home
  2. TROX vs AUPH Comparison

TROX vs AUPH Comparison

Compare TROX & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROX
  • AUPH
  • Stock Information
  • Founded
  • TROX 2018
  • AUPH 1993
  • Country
  • TROX United States
  • AUPH Canada
  • Employees
  • TROX N/A
  • AUPH N/A
  • Industry
  • TROX Major Chemicals
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TROX Industrials
  • AUPH Health Care
  • Exchange
  • TROX Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • TROX 949.2M
  • AUPH 1.1B
  • IPO Year
  • TROX 2005
  • AUPH 1999
  • Fundamental
  • Price
  • TROX $5.55
  • AUPH $8.77
  • Analyst Decision
  • TROX Buy
  • AUPH Strong Buy
  • Analyst Count
  • TROX 8
  • AUPH 2
  • Target Price
  • TROX $7.63
  • AUPH $11.50
  • AVG Volume (30 Days)
  • TROX 2.5M
  • AUPH 1.4M
  • Earning Date
  • TROX 07-31-2025
  • AUPH 07-31-2025
  • Dividend Yield
  • TROX 9.84%
  • AUPH N/A
  • EPS Growth
  • TROX N/A
  • AUPH N/A
  • EPS
  • TROX N/A
  • AUPH 0.27
  • Revenue
  • TROX $3,038,000,000.00
  • AUPH $247,295,000.00
  • Revenue This Year
  • TROX $3.06
  • AUPH $12.15
  • Revenue Next Year
  • TROX $4.86
  • AUPH $18.31
  • P/E Ratio
  • TROX N/A
  • AUPH $31.76
  • Revenue Growth
  • TROX 4.18
  • AUPH 29.20
  • 52 Week Low
  • TROX $4.35
  • AUPH $5.20
  • 52 Week High
  • TROX $17.45
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • TROX 52.40
  • AUPH 66.00
  • Support Level
  • TROX $4.96
  • AUPH $7.71
  • Resistance Level
  • TROX $5.71
  • AUPH $8.29
  • Average True Range (ATR)
  • TROX 0.25
  • AUPH 0.25
  • MACD
  • TROX -0.02
  • AUPH 0.03
  • Stochastic Oscillator
  • TROX 52.34
  • AUPH 84.40

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: